Interview With Timothy Ko

CEO of Entheon Biomedical, Timothy Ko, discusses how the company plans to utilize the psychedelic compound, DMT, to treat a variety of addictions.

Interview With Joshua White

Fireside Project’s Co-Founder and Director, Joshua White, speaks about the creation and the future of the organization.

Interview With Joshua Bartch

Mydecine Innovations Group’s Director, CEO & Co-Founder, Joshua Bartch chats with our Director of Content, Jill Ettinger.

Interview With Rabbi Zac Kamenetz

Founder and CEO of Shefa, and Co-Founder of the Jewish Psychedelic Summit, Rabbi Zac Kamenetz, speaks about the upcoming summit and the connection between Judaism and psychedelics.

Interview With Douglas K. Gordon

CEO of Silo Wellness, Douglas K. Gordon, speaks about the company’s expansion to the Frankfurt Exchange and the recent collaboration with the Bob Marley Estate.

Interview With Stephen Murphy

Stephen Murphy, Co-Founder of Prohibition Partners, chats about the upcoming PSYCH Investor Summit taking place on April 21, 2021.
dr. joseph tucker

Interview With Dr. Joseph Tucker

MagicMed Industries’ CEO, Dr. Joseph Tucker, talks about their psychedelic library, the company’s plans to go public and what the future of psychedelic research looks like.
Dustin Robinson

Interview With Dustin Robinson

Mr. Psychedelic Law’s Co-Founding Partner, Dustin Robinson, talks about how he became involved with the medicinal psychedelic space.

Interview With Nick Levich

Psychedelic Passage’s Co-Founder and Facilitator, Nick Levich, talks about the function, purpose and importance of a trip sitter during a psychedelic experience.

Interview With Pierre Bouchard

Psychotherapist, Pierre Bouchard talks with our Director of Content, Jill Ettinger.